CIENA Corp. (NYSE: CIEN) Q4 2020 earnings call dated Dec. 10, 2020 Corporate Participants: Gregg Lampf — Vice President, Investor Relations Gary B. Smith — President and
CIENA Corp. (CIEN) Q4 2020 Earnings Call Transcript

CIENA Corp. (NYSE: CIEN) Q4 2020 earnings call dated Dec. 10, 2020 Corporate Participants: Gregg Lampf — Vice President, Investor Relations Gary B. Smith — President and
Biofrontera AG (NASDAQ: BFRA) Q2 2020 earnings call dated Aug. 27, 2020. Call participants: Pamela Keck -- Head of Investor Relations Hermann Lubbert -- Managing Director
Listen to Walgreens Boots Alliance Inc. (WBA) Q4 2020 earnings conference call dated Oct. 15, 2020 Corporate Participants: Gerald Gradwell — Senior Vice President
New Frontier Health Corporation (NYSE: NFH) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: William Zima -- Investor Relations Roberta
OXFORD BIOMEDICA PLC (OTC: OXB) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Catherine Isted -- Head of Corporate Development
Innate Pharma S.A. (NASDAQ: IPHA) Q2 2020 earnings call dated Sep. 08, 2020. Corporate Participants: Mondher Mahjoubi -- Chairman of the Executive Board and
For UnitedHealth Group Inc. (NYSE: UNH), the early effect of coronavirus on its business was a marked reduction in costs due to
Bristol Myers Squibb (NYSE: BMY) agreed to acquire MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion in cash. The deal, which amounts to
Auris Medical Holding AG (NASDAQ: EARS) Q2 2020 earnings call dated Sep. 17, 2020. Corporate Participants: Thomas Meyer -- Chief Executive Officer
Applied Genetic Technologies Corp. (NASDAQ: AGTC) Q4 2020 earnings call dated Sep. 09, 2020 Corporate Participants: Sue Washer -- President and Chief Executive Officer
The healthcare sector was required to respond to the coronavirus outbreak in a proactive manner, unlike most other businesses. Cigna Corporation (NYSE:
Trinity Biotech plc (NASDAQ: TRIB) Q2 2020 earnings call dated Aug. 25, 2020 Corporate Participants: Kevin Tansley -- Chief Financial Officer Ronan O'Caoimh -- Chairman and
Lannett Inc. (NYSE: LCI) Q4 2020 earnings call dated Aug. 26, 2020 Corporate Participants: Robert Jaffe -- Investor Relations, Robert Jaffe Co., LLC Timothy
AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Rushmie Nofsinger -- Executive Director of Corporate Communications &
Ascendis Pharma A/S (NASDAQ: ASND) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: Scott T. Smith -- Senior Vice President and Chief
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by
Palatin Technologies Inc (NYSEAMERICAN : PTN) Q4 2020 earnings call dated Sep. 28, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer
https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at a time
Misonix Inc. (NASDAQ: MSON) Q4 2020 earnings call dated Sep. 03, 2020 Corporate Participants: Norberto Aja -- Investor Relations Stavros George Vizirgianakis -- President and Chief
Phreesia, Inc. (NYSE: PHR) Q2 2021 earnings call dated Sep. 09, 2020 Corporate Participants: Balaji Gandhi -- Investor Relations Chaim Indig -- Chief Executive Officer Tom